158 related articles for article (PubMed ID: 20618481)
1. New research advances for treating metastatic melanoma.
Minutilli E
Int J Dermatol; 2010 Jun; 49(6):712-4. PubMed ID: 20618481
[No Abstract] [Full Text] [Related]
2. [Not Available].
Eigentler TK
J Dtsch Dermatol Ges; 2015 Oct; 13(10):1055-6. PubMed ID: 26408485
[No Abstract] [Full Text] [Related]
3. Therapeutic use of erythropoietin in dermatooncology.
Satzger I; Schenck F; Thol F; Ganser A; Kapp A; Gutzmer R
J Dtsch Dermatol Ges; 2007 Apr; 5(4):280-5. PubMed ID: 17376091
[TBL] [Abstract][Full Text] [Related]
4. [What is new in oncodermatology?].
Robert C
Ann Dermatol Venereol; 2008 Dec; 135 Suppl 7():S354-9. PubMed ID: 19264211
[TBL] [Abstract][Full Text] [Related]
5. [What's new in oncology?].
Dalle S
Ann Dermatol Venereol; 2012 Dec; 139 Suppl 5():S217-22. PubMed ID: 23522708
[TBL] [Abstract][Full Text] [Related]
6. [New breakthroughs in Oncodermatology].
Mortier L
Ann Dermatol Venereol; 2010 Dec; 137 Suppl 4():S158-64. PubMed ID: 21193119
[TBL] [Abstract][Full Text] [Related]
7. [Working group of Dermatologic Oncology ADO. Second-line therapy in stage IV melanoma].
J Dtsch Dermatol Ges; 2007 Oct; 5(10):959. PubMed ID: 17910683
[No Abstract] [Full Text] [Related]
8. Metastatic melanoma. The latest treatment options.
Gale D
Adv Nurse Pract; 1998 May; 6(5):42-6. PubMed ID: 9633289
[No Abstract] [Full Text] [Related]
9. Chemotherapy in metastatic melanoma - still useful or out of date?
Ugurel S
Onkologie; 2011; 34(4):159-60. PubMed ID: 21447971
[No Abstract] [Full Text] [Related]
10. Treatment for metastatic malignant melanoma: old drugs and new strategies.
Mouawad R; Sebert M; Michels J; Bloch J; Spano JP; Khayat D
Crit Rev Oncol Hematol; 2010 Apr; 74(1):27-39. PubMed ID: 19781957
[TBL] [Abstract][Full Text] [Related]
11. [Working group of the Dermatologic Oncology].
Hauschild A; Schadendorf D
J Dtsch Dermatol Ges; 2009 Aug; 7(8):726-7. PubMed ID: 19708958
[No Abstract] [Full Text] [Related]
12. [What's new in skin cancers?].
Jouary T
Ann Dermatol Venereol; 2014 Dec; 141 Suppl 4():S630-42. PubMed ID: 25539755
[TBL] [Abstract][Full Text] [Related]
13. Recent aspects of medical care of malignant melanoma.
Terheyden P; Tilgen W; Hauschild A
J Dtsch Dermatol Ges; 2008 Oct; 6(10):868-78, 868-80. PubMed ID: 18992025
[TBL] [Abstract][Full Text] [Related]
14. Malignant melanoma: molecular cytogenetics and their implications in clinical medicine.
Junkins-Hopkins JM
J Am Acad Dermatol; 2010 Aug; 63(2):329-32. PubMed ID: 20633801
[No Abstract] [Full Text] [Related]
15. [Dermatological Association of Oncology (ADO)].
Trefzer U
J Dtsch Dermatol Ges; 2008 Oct; 6(10):899. PubMed ID: 18992034
[No Abstract] [Full Text] [Related]
16. Reactive oxygen species may have antitumor activity in metastatic melanoma.
Tuma RS
J Natl Cancer Inst; 2008 Jan; 100(1):11-2. PubMed ID: 18159075
[No Abstract] [Full Text] [Related]
17. Nivolumab success in untreated metastatic melanoma.
Wilkinson E
Lancet Oncol; 2015 Jan; 16(1):e9. PubMed ID: 25638562
[No Abstract] [Full Text] [Related]
18. [Electric chemotherapy in extensive tumor infiltration of skin and subcutaneous tissue --a valuable extension of dermato-oncologic armamentariums].
Kretschmer L
J Dtsch Dermatol Ges; 2015 Apr; 13(4):271-2. PubMed ID: 25819231
[No Abstract] [Full Text] [Related]
19. Management of metastatic melanoma.
Tawbi HA; Kirkwood JM
Semin Oncol; 2007 Dec; 34(6):532-45. PubMed ID: 18083377
[TBL] [Abstract][Full Text] [Related]
20. Randomized trials in melanoma: an update.
Eggermont AM
Surg Oncol Clin N Am; 2006 Apr; 15(2):439-51. PubMed ID: 16632225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
